TRDA Stock Forecast - Entrada Therapeutics Inc

	Entrada Therapeutics Inc NASDAQ:TRDA	US
A	AP Thailand PCL SET:AP	TH
K	Kyocera Corp F:KYR	JP
K	Komatsu Ltd XMUN:KOM1	JP
T	Thong Nhat Rubber JSC VN:TNC	VN
M	Muramoto Electron Thailand PCL SET:METCO	TH
F	FAE Technology SpA SB MIL:FAE	IT
	Bionomics Ltd F:B1N	AU
I	Iridium Communications Inc XBER:6IC	US
H	Harley-Davidson Inc DUS:HAR	US

Wall St Price Targets

Wall Street analysts forecast TRDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRDA is 16.98 USD with a low forecast of 7.31 USD and a high forecast of 26.25 USD.

TRDA Lowest Forecast

2% Upside

TRDA Average Forecast

137% Upside

TRDA Highest Forecast

266% Upside

2% Upside

137% Upside

266% Upside

Afya Ltd

13% Upside

Kearny Financial Corp

8% Upside

Central Garden & Pet Co

26% Upside

ProQR Therapeutics NV

334% Upside

Afya Ltd

13% Upside

Kearny Financial Corp

8% Upside

Central Garden & Pet Co

26% Upside

ProQR Therapeutics NV

334% Upside

Revenue
Forecast

N/A

Past Growth

45% / Year

Estimated Growth

Estimates Accuracy

11%

Average Beat

N/A

Past Growth

45% / Year

Estimated Growth

Estimates Accuracy

11%

Average Beat

The compound annual growth rate for Revenue over the next 8 years is 45%.

What are analyst estimates?

Gross Profit
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-7%

Average Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-7%

Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-5%

Average Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-5%

Average Miss

What are analyst estimates?

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-3%

Average Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-3%

Average Miss

What are analyst estimates?

Continue TRDA Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

According to Wall Street analysts, the average 1-year price target for TRDA is 16.98 USD with a low forecast of 7.31 USD and a high forecast of 26.25 USD.

The compound annual growth rate for Revenue over the next 8 years is 45%.

Back to Top

Entrada Therapeutics Inc
NASDAQ:TRDA

Wall St Price Targets

TRDA Price Targets Summary
Entrada Therapeutics Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue TRDA Research

What is TRDA's stock price target?

Price Target
16.98 USD

What is the Revenue forecast for Entrada Therapeutics Inc?

Projected CAGR
45%

Company

Help

Tools

Stocks

Entrada Therapeutics Inc NASDAQ:TRDA

Wall St Price Targets

TRDA Price Targets Summary Entrada Therapeutics Inc

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue TRDA Research

What is TRDA's stock price target? Price Target 16.98 USD

What is the Revenue forecast for Entrada Therapeutics Inc? Projected CAGR 45%

Company

Help

Tools

Stocks

Entrada Therapeutics Inc
NASDAQ:TRDA

TRDA Price Targets Summary
Entrada Therapeutics Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is TRDA's stock price target?

Price Target
16.98 USD

What is the Revenue forecast for Entrada Therapeutics Inc?

Projected CAGR
45%